Cookie settings

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use natcan.org.uk, remember your settings and improve our services.

We also use cookies set by other sites to help us deliver content from their services.

View cookies
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Skip to main content
National Cancer Audit Collaborating Centre logo
  • About NATCAN
  • Our impact
  • For the public
  • News
  • Events
  • FAQs
  • Audits
  • Data dashboards
  • Reports
  • Library
  • Quality Improvement
  • Bowel
  • Kidney
  • Lung
  • Metastatic Breast
  • Non-Hodgkin Lymphoma
  • Oesophago-Gastric
  • Ovarian
  • Pancreatic
  • Primary Breast
  • Prostate
    • Bowel
    • Kidney
    • Lung
    • Metastatic Breast
    • Non-Hodgkin Lymphoma
    • Oesophago-Gastric
    • Ovarian
    • Pancreatic
    • Primary Breast
    • Prostate
  • Data dashboards
  • Reports
  • Library
  • Quality Improvement
  • About NATCAN
  • Our impact
  • For the public
  • News
  • Events
  • FAQs
  1. Home
  2. Audits
  3. National Audit of Metastatic Breast Cancer (NAoMe)

NAoMe Quality Improvement

NAoMe Quality Improvement Plan 2024

NAoMe Quality Improvement Plan

NAoMe Metrics Table 2024

NAoMe Metrics Table 2024

The NAoMe Quality Improvement Plan describes the approach taken across the NATCAN cancer audits to develop improvement goals and performance indicators / metrics, aiming for these to be measurable, actionable and improvable.

The NAoMe Quality Improvement goals, developed following a thorough scoping exercise in 2023 and in consultation with stakeholders in the Audit Advisory Committee, are as follows:

  1. Improve the movement of patients through the care pathway.
  2. Reduce unwarranted variation in access and timeliness to systemic anti-cancer treatment.
  3. Reduce unwarranted variation in access and timeliness to palliative treatments.
  4. Improve access to nursing support.
  5. Improve and reduce variation in metastatic breast cancer outcomes.

The NAoMe has identified ten indicators / metrics to monitor progress against these five improvement goals and how they map to clinical guidelines and standards. A range of improvement methods and improvement activities to help deliver the Quality Improvement Plan are also described.

For more information about the NAoMe, please visit our audit page.

For any queries relating to this please contact [email protected].

Share this page

In this section

  • About NAoMe
  • NAoMe State of the Nation report 2025
  • NAoMe Quality Improvement
  • Meet the NAoMe team
  • NAoMe FAQs
  • Contact NAoMe
National Cancer Audit Collaborating Centre logo

Sign up for updates from NATCAN

Subscribe

Follow NATCAN

HQIP
Royal College of Surgeons of England
  • Contact
  • Accessibility
  • Privacy
  • Cookies
  • Terms and conditions
  • Working with us

Copyright © 2025 National Cancer Audit Collaborating Centre

Lovingly crafted by Mixd